<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00351494</url>
  </required_header>
  <id_info>
    <org_study_id>HP06-HM/FIBROME</org_study_id>
    <nct_id>NCT00351494</nct_id>
  </id_info>
  <brief_title>Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization</brief_title>
  <official_title>Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contrast-enhanced ultrasound is supposed to improve the detection of myomas as well as
      improve the follow-up after specific treatments like embolization. It will also help the
      investigators better understand the mechanism of success or failure for embolization and
      could reduce the amount of particles injected by determining the endpoint of the procedure in
      order to treat the myomas while preserving the myometrium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before embolization of the uterine artery, 40 patients with unique or multiple myomas will be
      included prospectively in our study and evaluated with sonography before and after injection
      of Sonovue (2.4 ml) (Bracco Int Milano Italy). Pelvic ultrasound with contrast enhancement
      will be done the day after and six months after the procedure.

      Microvascularization of the myomas and the endometrium will be described. Some tiny myomas
      which are not visible on conventional sonography could be identified for a perfect matching
      with MRI detection.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2006</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate the usefulness of contrast-enhanced ultrasound with real-time imaging technique in the assessment of vascular patterns from myomas myometrium and ovaries before and after uterine artery embolization</measure>
    <time_frame>Inclusion period and follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accordance between contrast-enhanced imaging and IRM</measure>
    <time_frame>inclusion period and follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accordance between early vascular patterns due to embolization of the fibroma and the success of the technique which is evaluated after 6 month</measure>
    <time_frame>inclusion period and follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between the post embolization pain and the vascular change of the fibroma and the myometrium</measure>
    <time_frame>inclusion period</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myoma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>contrast enhanced ultrasonography</intervention_name>
    <description>Three contrast-enhanced ultrasonography : before embolization, after one day and after 6 months.
Abdominal route 2.4 ml sonovue per injection / bolus</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>embolization</intervention_name>
    <description>Intervention is described in the case report form for each patient</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women candidate for embolization of myomas
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uterine myomas with solid tissue (greater diameter lower than 15 cm)

          -  The embolization is planified during the 15 days after the contrast ultrasonography

          -  Written informed consent is signed

        Exclusion Criteria:

          -  Intracavitary uterine mass possibly due to a polyp or endometrial cancer

          -  Necessity of using the endovaginal way of ultrasonography because of the myoma's size
             and accessibility

          -  Menopause

          -  Pregnancy and breastfeeding

          -  Recent cardiac affection

          -  History of acute cardiac disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henri MARRET, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Gynécologie Obstétrique CHRU TOURS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François TRANQUART, Pr</last_name>
    <role>Study Director</role>
    <affiliation>Centre d'Innovation Technologique CHRU TOURS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henri MARRET, Pr</last_name>
    <phone>(33) 2 47 47 82 59</phone>
    <email>marret@med.univ-tours.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine ROUSSEL, ARC</last_name>
    <phone>(33) 2 47 47 97 89</phone>
    <email>roussel@med.univ-tours.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre d'Innovation Technologique-Ultrasons</name>
      <address>
        <city>Tours</city>
        <zip>37344</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henri MARRET, Pr</last_name>
      <phone>(33) 2 47 47 82 59</phone>
      <email>marret@med.univ-tours.fr</email>
    </contact>
    <contact_backup>
      <last_name>Catherine ROUSSEL, ARC</last_name>
      <phone>(33) 2 47 47 97 89</phone>
      <email>roussel@med.univ-tours.fr</email>
    </contact_backup>
    <investigator>
      <last_name>François TRANQUART, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurore BLEUZEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denis HERBRETEAU, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc LEGEAIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie WAGNER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Tranquart F, Brunereau L, Cottier JP, Marret H, Gallas S, Lebrun JL, Body G, Herbreteau D, Pourcelot L. Prospective sonographic assessment of uterine artery embolization for the treatment of fibroids. Ultrasound Obstet Gynecol. 2002 Jan;19(1):81-7.</citation>
    <PMID>11851974</PMID>
  </reference>
  <reference>
    <citation>Marret H, Cottier JP, Alonso AM, Giraudeau B, Body G, Herbreteau D. Predictive factors for fibroids recurrence after uterine artery embolisation. BJOG. 2005 Apr;112(4):461-5.</citation>
    <PMID>15777445</PMID>
  </reference>
  <reference>
    <citation>Marret H, Tranquart F, Sauget S, Alonso AM, Cottier JP, Herbreteau D. Contrast-enhanced sonography during uterine artery embolization for the treatment of leiomyomas. Ultrasound Obstet Gynecol. 2004 Jan;23(1):77-9.</citation>
    <PMID>14971005</PMID>
  </reference>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2006</study_first_submitted>
  <study_first_submitted_qc>July 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2006</study_first_posted>
  <last_update_submitted>November 21, 2007</last_update_submitted>
  <last_update_submitted_qc>November 21, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2007</last_update_posted>
  <keyword>embolization</keyword>
  <keyword>contrast enhanced ultrasound</keyword>
  <keyword>myoma</keyword>
  <keyword>uterine artery</keyword>
  <keyword>microvascularisation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

